[1] CAMPO G, SAIA F, GUASTAROBA P, et al. Prognostic impact of hospital readmissions after primary percutaneous coronary intervention[J]. Arch Intern Med, 2011, 171(21):1948-1949. [2] NG V G, LANSKY A J, MELLER S, et al. The prognostic importance of left ventricular function in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial[J]. Eur Heart J Acute Cardiovasc Care, 2014, 3(1):67-77. [3] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南(2019)[J]. 中华心血管病杂志, 2019, 47(10):766-783. [4] COKKINOS D V, BELOGIANNEAS C. Left ventricular remodelling: a problem in search of solutions[J]. Eur Cardiol, 2016, 11(1):29. [5] CHEW D S, WILTON S B, KAVANAGH K, et al. Left ventricular ejection fraction reassessment post-myocardial infarction: current clinical practice and determinants of adverse remodeling[J]. Am Heart J, 2018, 198:91-96. [6] MUKHERJEE J T, BESHANSKY J R, RUTHAZER R, et al. In-hospital measurement of left ventricular ejection fraction and one-year outcomes in acute coronary syndromes: results from the IMMEDIATE Trial[J]. Cardiovasc Ultrasound, 2015, 14(1):29. [7] PERELSHTEIN BREZINOV O, KLEMPFNER R, ZEKRY S B, et al. Prognostic value of ejection fraction in patients admitted with acute coronary syndrome: a real world study[J]. Medicine: Baltimore, 2017, 96(9): e6226. [8] 饶福涛. 老年急性心肌梗死伴左心室收缩功能障碍临床特征及危险因素[J]. 中国老年学杂志, 2019, 39(22): 5414-5418. [9] DE WAHA S, EITEL I, DESCH S, et al. Prognosis after ST-elevation myocardial infarction: a study on cardiac magnetic resonance imaging versus clinical routine[J]. Trials, 2014, 15(1): 249. [10] PASCERI V, PRISTIPINO C, PELLICCIA F, et al. Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction[J]. Am J Cardiol, 2005, 95(11):1358-1361. [11] MOVAHED M R, BUTMAN S M. The pathogenesis and treatment of no-reflow occurring during percutaneous coronary intervention[J]. Cardiovasc Revasc Med, 2008, 9(1):56-61. [12] ASAAD N, EL-MENYAR A, ALHABIB K F, et al. Initial heart rate and cardiovascular outcomes in patients presenting with acute coronary syndrome[J]. Acute Card Care, 2014, 16(2):49-56. [13] ROTH D, VAN TULDER R, HEIDINGER B, et al. Admission blood pressure and 1-year mortality in acute myocardial infarction[J]. Int J Clin Pract, 2015, 69(8):812-819. [14] CLERICO A, PASSINO C. Predictive value of NT-proBNP in patients with acute myocardial infarction[J]. Clin Chem, 2017, 63(5):1045-1046. |